Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/13/25 16:30 | 2/3/25 | ELUT | Health | BioPrd | Biological Products, (No Diag | Highcape Capital, L.P. | CT | DT | P | 1,050 | 2.50 | 0 | 420 | 5 | 9,520 | I | |||||||||||||||
3/13/25 16:28 | 2/3/25 | ELUT | Health | BioPrd | Biological Products, (No Diag | Highcape Capital, L.P. | CT | DT | P | 1,050 | 2.50 | 0 | 420 | 5 | 9,520 | I | |||||||||||||||
2/20/24 12:27 | 3/23/23 | ELUT | Health | BioPrd | Biological Products, (No Diag | Birchview Capital, LP | VT | H | 10% owne | P.am | 207 | 1.48 | 0 | 140 | 9 | 1,655 | I | ||||||||||||||
10/5/23 16:50 | 9/21/21 | ELUT | Health | BioPrd | Biological Products, (No Diag | Highcape Capital, LLC | CT | T | P.d | 0 | 0.00 | 0 | 2,837 | 51 | 8,435 | I | |||||||||||||||
10/5/23 16:43 | 9/21/21 | ELUT | Health | BioPrd | Biological Products, (No Diag | Highcape Capital, L.P. | CT | DT | P.d | 0 | 0.00 | 0 | 2,837 | 51 | 8,435 | I | |||||||||||||||
3/27/23 16:17 | 3/23/23 | AZYO | Health | BioPrd | Biological Products, (No Diag | Birchview Capital, LP | VT | T | P.m | 207 | 1.48 | 0 | 140 | 9 | 1,655 | I | |||||||||||||||
2/13/23 19:01 | 5/11/22 | AZYO | Health | BioPrd | Biological Products, (No Diag | Birchview Capital, LP | VT | T | P.m | 398 | 4.09 | 0 | 97 | 7 | 1,515 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |